Efficacy of Stellate Ganglion Block in Obstructive Sleep Apnea
- Conditions
- Obstructive Sleep Apnea
- Interventions
- Behavioral: routine rehabilitation treatmentProcedure: Stellate ganglion block
- Registration Number
- NCT06265792
- Lead Sponsor
- Zeng Changhao
- Brief Summary
The goal of this clinical trial is to test the efficacy of stellate ganglion block in Obstructive Sleep Apnea. The main question it aims to answer are:
• Can stellate ganglion block improve Obstructive Sleep Apnea? Patients were randomly divided into two groups, all provided with routine therapy. Based on this, the experimental group was given stellate ganglion block. The video fluoroscopic swallowing study was done to test the swallowing function before and after the study.
- Detailed Description
Obstructive Sleep Apnea is of increasingly high prevalence.
The goal of this clinical trial is to test the efficacy of stellate ganglion block in Obstructive Sleep Apnea. The main question it aims to answer are:
• Can stellate ganglion block improve Obstructive Sleep Apnea? Patients were randomly divided into two groups, all provided with routine therapy. Based on this, the experimental group was given stellate ganglion block. The video fluoroscopic swallowing study was done to test the swallowing function before and after the study.
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 80
- Patients aged over 18 years diagnosed with OSA by polysomnography
- Patients with moderate to severe OSA (AHI > 15 events per hour)
- Patients who have undergone continuous positive airway pressure (CPAP) treatment for at least 3 months but have not achieved satisfactory therapeutic effects
- Patients who voluntarily agree to receive stellate ganglion block (SGB) treatment and sign the informed consent form
- Patients with a history of allergy or contraindications to local anesthetics or corticosteroids
- Patients with severe cardiovascular, cerebrovascular, respiratory, hepatic, or renal diseases
- Patients with a history of neck surgery or cervical spine disease
- Patients with psychiatric disorders or other medical conditions that may affect the safety or effectiveness of SGB treatment
- Pregnant or lactating women
- Patients who have participated in other clinical trials within the past 3 months
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description The experimental group routine rehabilitation treatment All participants were given routine rehabilitation treatment by professional rehabilitation therapists, including exercise therapy, guided education, psychological therapy, acupuncture and massage therapy.The experimental group was given Stellate Ganglion Block. The experimental group Stellate ganglion block All participants were given routine rehabilitation treatment by professional rehabilitation therapists, including exercise therapy, guided education, psychological therapy, acupuncture and massage therapy.The experimental group was given Stellate Ganglion Block. The control group routine rehabilitation treatment All participants were given routine rehabilitation treatment by professional rehabilitation therapists, including exercise therapy, guided education, psychological therapy, acupuncture and massage therapy.
- Primary Outcome Measures
Name Time Method Epworth Sleepiness Scale day 1 and day 20 This scale measures daytime sleepiness. By scoring the level of sleepiness in different situations, it can help evaluate whether a patient has OSA or other sleep disorders.Scores range from 0-24. Higher scores indicate more severe daytime sleepiness.
- Secondary Outcome Measures
Name Time Method Apnea-Hypopnea Index day 1 and day 20 Apnea-Hypopnea Index is a method to evaluate the severity of OSA. It calculates the number of apnea and hypopnea events per hour.
Trial Locations
- Locations (1)
Center Rehabilitation Hospital
🇰🇷Seoul, Korea, Republic of